Brazil 3D Printing Medical Devices Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The development of medical devices in Brazil is becoming more and more affected by the fact that such devices can be produced on-site and customized for each particular patient, thus becoming less dependent on the traditional process of centralized manufacture. An appropriate comparison for this process can be made through the example of 3D Systems, which reported in March 2025 about successfully manufacturing a patient-specific facial implant at a hospital using the company’s EXT 220 MED technology and PEEK material by Evonik. Although the procedure occurred outside Brazil, the development is relevant to Brazilian hospitals and device manufacturers evaluating hospital-based additive manufacturing. The technology demonstrates that regulated implant production can move closer to surgical centres, potentially shortening design-to-treatment timelines for complex craniofacial procedures and supporting customised device production where conventional inventory-based models are less suitable.

Brazilian startups are using additive manufacturing to address the cost barrier associated with imported prosthetic devices. LimbX, a Brazilian MedTech company specialising in upper-limb prostheses, states that its devices are designed and manufactured domestically using 3D printing and proprietary technology. According to the company, its solutions can cost up to 90% less than imported alternatives while retaining functional and customisable characteristics. The company also describes its designs as modular and personalised, with validation involving real patients. This model is particularly relevant for Brazil because lower manufacturing costs can support broader access to upper-limb prostheses while allowing individualised fitting. The emergence of domestic manufacturers such as LimbX is therefore expanding additive manufacturing beyond institutional projects toward commercially oriented assistive medical-device production.

The additive manufacturing landscape of Brazil is shifting towards specialised materials for making customised maxillofacial prostheses instead of depending on conventional printing materials alone. Projects related to Bio.Inn and BioEdtech for creating new materials for making multifunctional and customised bucomaxillofacial prostheses through the use of Health 4.0 technologies have been cited in a 2025 CTI Renato Archer management report. It highlights the trend of merging material creation, digital design and additive manufacturing of devices with unique functional and anatomical features. Such materials can potentially expand the range of patient-specific facial and oral devices that can be manufactured domestically. This direction is relevant to Brazil's medical-device industry because locally developed materials may reduce dependence on imported specialised inputs and create opportunities for domestic companies across biomaterials, printing technologies and customised prosthetic manufacturing.

Digital impression systems are currently being explored as an alternative to physical impressions to develop dental devices in Brazil. In particular, a registered clinical trial by the ReBEC clinical trials register of Brazil in February 2026 compares the use of photogrammetry, intraoral scanning, and traditional methods to create full-arch implant-supported fixed dental prostheses. In this regard, the accuracy of these methods is evaluated. This development matters for 3D printing because accurate digital capture is an essential upstream step before CAD design and additive manufacturing. Greater adoption of intraoral scanning and photogrammetry can therefore strengthen the digital pipeline feeding Brazilian dental laboratories and manufacturers, particularly for full-arch and implant-supported applications where dimensional accuracy and patient-specific fit are important.

Brazilian healthcare programmes are increasingly linking 3D-printed devices with multidisciplinary rehabilitation, rather than treating printing as an isolated manufacturing activity. In March 2026, HU-Univasf and its partners launched a multiprofessional good-practice guide covering the safe and appropriate use of 3D-printed orthoses, prostheses and assistive technologies. The project involves HU-Univasf, HC-UFPE, Univasf, Biotech, Instituto Internacional Despertando Vocações and Associação Petrolinense de Atletismo. The initiative focuses on patient guidance covering physical and mental health, nutrition and rights alongside the use of 3D-printed devices. This approach broadens the application of additive manufacturing from device production toward complete rehabilitation pathways, potentially increasing demand for customised prostheses and orthoses that can be modified as patients' functional requirements change.